Is Bcr-Abl expression relevant for the survival of cancer stem cells in chronic myeloid leukaemia (CML)?

被引：0
|
作者：
Helgason, G. V. [1 ]
Hamilton, A. [1 ]
Myssina, S. [2 ]
Jorgensen, H. G. [1 ]
Bhatia, R. [3 ]
Modi, H. [3 ]
Schemionek, M. [4 ]
Koschmieder, S. [4 ]
Brunton, V.
Holyoake, T. L. [1 ,5 ]
机构：
[1] Univ Glasgow, Fac Med, Paul Ogorman Leukaemia Res Ctr, Sect Expt Haematol,Div Canc Sci & Mol Pathol, Glasgow, Lanark, Scotland
[2] Newcastle Univ, Sch Med, Newcastle Upon Tyne, Tyne & Wear, England
[3] City Hope Hosp, Dept Haematol, Duarte, CA USA
[4] Univ Munster, Dept Haematol & Med Oncol, D-4400 Munster, Germany
[5] Univ Edinburgh, Inst Genet & Mol Med, Div Canc Biol, Edinburgh, Midlothian, Scotland
来源：
BRITISH JOURNAL OF HAEMATOLOGY | 2010年 / 149卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
178
引用
收藏
页码：72 / 72
页数：1
相关论文
共 50 条
  • [1] BCR-ABL peptide immunisation in chronic myeloid leukaemia (CML)
    Clark, RE
    Knight, K
    Wang, L
    Rojas, JM
    EXPERIMENTAL HEMATOLOGY, 2005, 33 (07) : 54 - 54
  • [2] Chronic myeloid leukemia stem cells are not dependent on Bcr-Abl kinase activity for their survival
    Hamilton, Ashley
    Helgason, G. Vignir
    Schemionek, Mirle
    Zhang, Bin
    Myssina, Svetlana
    Allan, Elaine K.
    Nicolini, Franck E.
    Mueller-Tidow, Carsten
    Bhatia, Ravi
    Brunton, Valerie G.
    Koschmieder, Steffen
    Holyoake, Tessa L.
    BLOOD, 2012, 119 (06) : 1501 - 1510
  • [3] PREVALENCE OF BCR-ABL IMATINIB RESISTANT MUTATIONS IN PORTUGUESE CHRONIC MYELOID LEUKAEMIA (CML) PATIENTS
    Palmeiro, A.
    Torres, F.
    Lemos, R.
    Teixeira, M.
    Gabriel, H.
    Rendeiro, P.
    Tavares, M.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2010, 95 : 539 - 539
  • [4] BCR-ABL targeted therapy in chronic myeloid leukemia (CML).
    Goldman, JM
    Deininger, M
    Melo, JV
    EXPERIMENTAL HEMATOLOGY, 1997, 25 (08) : 515 - 515
  • [5] BCR-ABL fusion peptides and cytotoxic T cells in chronic myeloid leukaemia
    Clark, RE
    Christmas, SE
    LEUKEMIA & LYMPHOMA, 2001, 42 (05) : 871 - 880
  • [6] Effect of BCR-ABL inhibition on induction of autophagy in chronic myeloid leukaemia cells
    Mackay, C. E.
    Allen, E. K.
    Mukhopadhyay, A.
    Karvela, M.
    Holyoake, T. L.
    Jorgensen, H. G.
    Helgason, G. V.
    BRITISH JOURNAL OF HAEMATOLOGY, 2012, 157 : 58 - 58
  • [7] A pharmacodynamic model of Bcr-Abl signalling in chronic myeloid leukaemia
    Jackson, Robert C.
    Radivoyevitch, Tomas
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2014, 74 (04) : 765 - 776
  • [8] BCR-ABL monitoring by polymerase chain reaction (PCR) post allograft for chronic myeloid leukaemia (CML)
    Whittle, A. M.
    Smith, G. M.
    Evans, P.
    BRITISH JOURNAL OF HAEMATOLOGY, 2008, 141 : 47 - 47
  • [9] BCR-ABL fusion gene and BCR-ABL transcript -: Correlation with response to therapy in Chronic Myeloid Leukaemia.
    Geraldes, C
    Gonçalves, AC
    Santos, P
    Tavares, P
    Teixeira, A
    BLOOD, 2005, 106 (11) : 297B - 297B
  • [10] BCR-ABL expression in leukemic progenitors and primitive stem cells of patients with chronic myeloid leukemia
    Chomel, Jean-Claude
    Sorel, Nathalie
    Guilhot, Joelle
    Guilhot, Francois
    Turhan, Ali G.
    BLOOD, 2012, 119 (12) : 2964 - 2965
12345